Brainstorm Cell (BCLI)

$0.35 0.00 (0.00%)
15:56 EDT BCLI Stock Quote Delayed 30 Minutes
James Brumley

Should Investors Chase the BCLI Doubler Into Monday’s Announcement?

By James Brumley, InvestorPlace Feature Writer
Brainstorm Cell Therapeutics has an interesting stem cell therapy to be sure, but a near-doubling in the value of BCLI in just two days may be pushing the limits of reason
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 24.27M
PE Ratio -1.08
EPS -0.32
Volume (Avg. Vol.) 241
Day's Range -
52-Week Range $0.13 - $1.90
Dividend & Yield N/A (N/A)